why choose us

First received: April 15, 2026

Clinical Trial: Pharmacokinetic (PK) Evaluation of Nalmefene Formulations

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Opioid Overdose

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open Label, Randomized, Single Dose, Three-Period Crossover Study in Healthy Subjects to Compare the Pharmacokinetic Profiles of Nalmefene Following Administration of Intravenous and Intram

Brief Summary: This study is designed to characterize the PK of nalmefene following IV bolus and IM injections using nalmefene 0.5 mg (0.94% MgCl2) and IV bolus of 0.5 mg nalmefene hydrochloride injection in healthy subjects.

Read more